Immunologic diseases, anti-inflammatory drugs, and Parkinson disease

A case-control study

James Howard Bower, D. M. Maraganore, B. J. Peterson, J. E. Ahlskog, Walter A Rocca

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.

Original languageEnglish (US)
Pages (from-to)494-496
Number of pages3
JournalNeurology
Volume67
Issue number3
DOIs
StatePublished - Aug 2006

Fingerprint

Immune System Diseases
Parkinson Disease
Case-Control Studies
Anti-Inflammatory Agents
Immediate Hypersensitivity
Pharmaceutical Preparations
Inflammation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Immunologic diseases, anti-inflammatory drugs, and Parkinson disease : A case-control study. / Bower, James Howard; Maraganore, D. M.; Peterson, B. J.; Ahlskog, J. E.; Rocca, Walter A.

In: Neurology, Vol. 67, No. 3, 08.2006, p. 494-496.

Research output: Contribution to journalArticle

Bower, James Howard ; Maraganore, D. M. ; Peterson, B. J. ; Ahlskog, J. E. ; Rocca, Walter A. / Immunologic diseases, anti-inflammatory drugs, and Parkinson disease : A case-control study. In: Neurology. 2006 ; Vol. 67, No. 3. pp. 494-496.
@article{ffe8ead51b3244be96abe99a84b693ef,
title = "Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study",
abstract = "The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.",
author = "Bower, {James Howard} and Maraganore, {D. M.} and Peterson, {B. J.} and Ahlskog, {J. E.} and Rocca, {Walter A}",
year = "2006",
month = "8",
doi = "10.1212/01.wnl.0000227906.99570.cc",
language = "English (US)",
volume = "67",
pages = "494--496",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Immunologic diseases, anti-inflammatory drugs, and Parkinson disease

T2 - A case-control study

AU - Bower, James Howard

AU - Maraganore, D. M.

AU - Peterson, B. J.

AU - Ahlskog, J. E.

AU - Rocca, Walter A

PY - 2006/8

Y1 - 2006/8

N2 - The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.

AB - The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.

UR - http://www.scopus.com/inward/record.url?scp=33747044127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747044127&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000227906.99570.cc

DO - 10.1212/01.wnl.0000227906.99570.cc

M3 - Article

VL - 67

SP - 494

EP - 496

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -